velban

the oncologist decided to administer velban as part of the combination chemotherapy protocol.

velban treatment requires careful monitoring of blood counts to detect potential toxicity.

the velban infusion was administered slowly over several minutes to minimize adverse reactions.

patients receiving velban therapy often experience nausea and fatigue as common side effects.

the standard velban dosage depends on the type and stage of cancer being treated.

velban resistance can develop in some cancer cells after prolonged treatment exposure.

the velban regimen typically involves multiple cycles administered at three-week intervals.

clinical trials have demonstrated velban efficacy in treating hodgkin lymphoma and testicular cancer.

velban must be handled with extreme caution due to its high toxicity level.

the medical team adjusted the velban protocol based on the patient's response to initial treatment.

hair loss and bone marrow suppression are serious side effects associated with velban.

velban works by inhibiting cell division in rapidly multiplying cancer cells.